247 related articles for article (PubMed ID: 12163849)
1. Light during darkness, melatonin suppression and cancer progression.
Blask DE; Dauchy RT; Sauer LA; Krause JA; Brainard GC
Neuro Endocrinol Lett; 2002 Jul; 23 Suppl 2():52-6. PubMed ID: 12163849
[TBL] [Abstract][Full Text] [Related]
2. Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events.
Blask DE; Sauer LA; Dauchy RT; Holowachuk EW; Ruhoff MS; Kopff HS
Cancer Res; 1999 Sep; 59(18):4693-701. PubMed ID: 10493527
[TBL] [Abstract][Full Text] [Related]
3. Circadian stage-dependent inhibition of human breast cancer metabolism and growth by the nocturnal melatonin signal: consequences of its disruption by light at night in rats and women.
Blask DE; Dauchy RT; Brainard GC; Hanifin JP
Integr Cancer Ther; 2009 Dec; 8(4):347-53. PubMed ID: 20042410
[TBL] [Abstract][Full Text] [Related]
4. Light contamination during the dark phase in "photoperiodically controlled" animal rooms: effect on tumor growth and metabolism in rats.
Dauchy RT; Sauer LA; Blask DE; Vaughan GM
Lab Anim Sci; 1997 Oct; 47(5):511-8. PubMed ID: 9355094
[TBL] [Abstract][Full Text] [Related]
5. Antineoplastic effects of melatonin on a rare malignancy of mesenchymal origin: melatonin receptor-mediated inhibition of signal transduction, linoleic acid metabolism and growth in tissue-isolated human leiomyosarcoma xenografts.
Dauchy RT; Blask DE; Dauchy EM; Davidson LK; Tirrell PC; Greene MW; Tirrell RP; Hill CR; Sauer LA
J Pineal Res; 2009 Aug; 47(1):32-42. PubMed ID: 19486272
[TBL] [Abstract][Full Text] [Related]
6. Melatonin uptake and growth prevention in rat hepatoma 7288CTC in response to dietary melatonin: melatonin receptor-mediated inhibition of tumor linoleic acid metabolism to the growth signaling molecule 13-hydroxyoctadecadienoic acid and the potential role of phytomelatonin.
Blask DE; Dauchy RT; Sauer LA; Krause JA
Carcinogenesis; 2004 Jun; 25(6):951-60. PubMed ID: 14754876
[TBL] [Abstract][Full Text] [Related]
7. Lighting for the human circadian clock: recent research indicates that lighting has become a public health issue.
Pauley SM
Med Hypotheses; 2004; 63(4):588-96. PubMed ID: 15325001
[TBL] [Abstract][Full Text] [Related]
8. 13-Hydroxyoctadecadienoic acid is the mitogenic signal for linoleic acid-dependent growth in rat hepatoma 7288CTC in vivo.
Sauer LA; Dauchy RT; Blask DE; Armstrong BJ; Scalici S
Cancer Res; 1999 Sep; 59(18):4688-92. PubMed ID: 10493526
[TBL] [Abstract][Full Text] [Related]
9. Dim light during darkness stimulates tumor progression by enhancing tumor fatty acid uptake and metabolism.
Dauchy RT; Blask DE; Sauer LA; Brainard GC; Krause JA
Cancer Lett; 1999 Oct; 144(2):131-6. PubMed ID: 10529012
[TBL] [Abstract][Full Text] [Related]
10. Growth and fatty acid metabolism of human breast cancer (MCF-7) xenografts in nude rats: impact of constant light-induced nocturnal melatonin suppression.
Blask DE; Dauchy RT; Sauer LA; Krause JA; Brainard GC
Breast Cancer Res Treat; 2003 Jun; 79(3):313-20. PubMed ID: 12846415
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of fatty acid transport and proliferative activity in tissue-isolated human squamous cell cancer xenografts perfused in situ with melatonin or eicosapentaenoic or conjugated linoleic acids.
Dauchy RT; Dauchy EM; Davidson LK; Krause JA; Lynch DT; Tirrell PC; Tirrell RP; Sauer LA; Van der Riet P; Blask DE
Comp Med; 2007 Aug; 57(4):377-82. PubMed ID: 17803052
[TBL] [Abstract][Full Text] [Related]
12. Dietary factors and growth and metabolism in experimental tumors.
Sauer LA; Blask DE; Dauchy RT
J Nutr Biochem; 2007 Oct; 18(10):637-49. PubMed ID: 17418560
[TBL] [Abstract][Full Text] [Related]
13. Human cancer xenograft perfusion in situ in rats: a new perfusion system that minimizes delivery time and maintains normal tissue physiology and responsiveness to growth-inhibitory agents.
Dauchy EM; Dauchy RT; Davidson LK; Lynch DT; Krause JA; Blue LM; Sauer LA; Blask DE
J Am Assoc Lab Anim Sci; 2006 May; 45(3):38-44. PubMed ID: 16642969
[TBL] [Abstract][Full Text] [Related]
14. Effect of melatonin on mammary carcinogenesis in intact and pinealectomized rats in varying photoperiods.
Shah PN; Mhatre MC; Kothari LS
Cancer Res; 1984 Aug; 44(8):3403-7. PubMed ID: 6430548
[TBL] [Abstract][Full Text] [Related]
15. The light-dark regimen and cancer development.
Anisimov VN
Neuro Endocrinol Lett; 2002 Jul; 23 Suppl 2():28-36. PubMed ID: 12163845
[TBL] [Abstract][Full Text] [Related]
16. Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats.
Blask DE; Brainard GC; Dauchy RT; Hanifin JP; Davidson LK; Krause JA; Sauer LA; Rivera-Bermudez MA; Dubocovich ML; Jasser SA; Lynch DT; Rollag MD; Zalatan F
Cancer Res; 2005 Dec; 65(23):11174-84. PubMed ID: 16322268
[TBL] [Abstract][Full Text] [Related]
17. Melatonin and mammary pathological growth.
Cos S; Sánchez-Barceló EJ
Front Neuroendocrinol; 2000 Apr; 21(2):133-70. PubMed ID: 10764528
[TBL] [Abstract][Full Text] [Related]
18. Mechanism for the antitumor and anticachectic effects of n-3 fatty acids.
Sauer LA; Dauchy RT; Blask DE
Cancer Res; 2000 Sep; 60(18):5289-95. PubMed ID: 11016660
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic actions of melatonin in cancer: possible mechanisms.
Srinivasan V; Spence DW; Pandi-Perumal SR; Trakht I; Cardinali DP
Integr Cancer Ther; 2008 Sep; 7(3):189-203. PubMed ID: 18815150
[TBL] [Abstract][Full Text] [Related]
20. Putting cancer to sleep at night: the neuroendocrine/circadian melatonin signal.
Blask DE; Dauchy RT; Sauer LA
Endocrine; 2005 Jul; 27(2):179-88. PubMed ID: 16217131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
